doi: 10.1242/10.1242/jcs.00081
Role of ß3-endonexin in the regulation of NF-
B-dependent expression of urokinase-type plasminogen activator receptor
Felicitas Besta1,
Steffen Massberg1,
Korbinian Brand2,
Elke Müller1,
Sharon Page2,
Sabine Grüner1,
Michael Lorenz1,
Karin Sadoul3,
Waldemar Kolanus4,
Ernst Lengyel5 and
Meinrad Gawaz1,*
1 1. Medizinische Klinik, Klinikum rechts der Isar und Deutsches Herzzentrum,
Lazarettstraße 36, 80636 München, Germany
2 Institut für Klinische Chemie und Pathobiochemie, Technische
Universität München, Ismaningerstraße 22, 81675 München,
Germany
3 Institut Albert Bonniot, Joseph Fourier University of Grenoble, Faculty of
Medicine, Domaine de la Merci, 38706 La Tronche Cedex, France
4 Laboratorium für Molekulare Biologie, Genzentrum der Universität
München, Feodor Lynen Strasse 25, 81377 München, Germany
5 Department of Obstetrics, Gynecology and Reproductive Sciences, University of
California San Francisco Comprehensive Cancer Center, San Francisco, CA
94143-0875, USA

View larger version (37K):
[in a new window]
|
Fig. 1. The cytoplasmic protein ß3-endonexin downregulates uPAR
protein expression in endothelial cells. (A) Immunoblot of endogenous
ß3-endonexin. Lysates of platelets, HUVECs and human placenta
tissue were evaluated by immunoblotting with the help of a specific polyclonal
anti-ß3-endonexin antiserum. A purified recombinant His-tagged
ß3-endonexin (14 kDa) served as antigen control. (B) FACS.
Confluent monolayers of endothelial cells were transiently transfected with
GFP/En-S, GFP/En-L, or GFP control vector. After 48 hours cells were stained
with anti-uPAR mAb and evaluated by flow cytometry. The mean
intensity±s.e.m. of uPAR immunofluorescence of GFP-positive cells in
four experiments was used as an index of uPAR protein expression.
|
|

View larger version (45K):
[in a new window]
|
Fig. 2. ß3-endonexin downregulates uPAR promoter activity. (A)
CAT-assay. CHO cells were transiently co-transfected with the -398 bp fragment
of the uPAR promoter (uPAR-CAT -398) (1 µg), a luciferase vector for
normalization and various concentrations of expression vectors encoding the
short or long form of ß3-endonexin or the mock expression
vector (GFP). Cell extracts normalized for luciferase activity were incubated
with [14C]chloramphenicol, extracted with ethyl acetate, and
subjected to thin-layer chromatography. The conversion of
[14C]chloramphenicol to acetylated derivatives was quantified using
BioRad GelDoc scanning software. (B) Histobars depict the results
(mean±s.e.m.) of the CAT-assays performed as described in A with 3
µg of the expression vector. The data shown is representative of six
independently performed experiments.
|
|

View larger version (43K):
[in a new window]
|
Fig. 5. ß3-endonexin binds to p50/p65 complex and inhibits p50-DNA
binding. (A) Immunoprecipitation. Confluent monolayers of endothelial cells
were transfected with GFP/En-S, GFP/En-L or control vector.
Immunoprecipitation was performed with anti-p65 or anti-GFP mAb and Agarose A.
Thereafter, immunoprecipitate was probed by anti-GFP or anti-p65, by
immunoblotting. (B) Pull-down. Recombinant p50 was incubated with GST/En-S,
GST/En-L or GST, which were immobilized on Sepharose. The precipitate and the
supernatant were probed by immunoblotting using anti-p50 mAb.
Anti-GST-blotting showed equal expression of the fusion proteins. (C) EMSA.
Recombinant p50 was incubated with increasing ratios (1:2, 1:3, 1:4) of
GST-En-S, GST-En-L or GST, and binding of B-DNA was determined by EMSA.
(D) Pulldown. Recombinant p50 was incubated with double-stranded consensus or
mutated B oligonucleotides and subsequently precipitated with
immobilized GST/En-S or GST/En-L proteins. The precipitate was evaluated for
p50 binding by immunoblotting. Equal amounts of GST proteins was confirmed
with an anti-GST pAb. (E) Pull-down. As described in D, p50 protein was
incubated with double-stranded B consensus or B uPAR
oligonucleotides, which contained the specific NF- B sequence of the
uPAR promoter and GST/En-L. B uPAR was used in raising ratios.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
© The Company of Biologists Ltd 2002